Improve the Quality of Care in Patients With Orthopaedic Disorders
Launched by CLINIQUES UNIVERSITAIRES SAINT-LUC- UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Jan 30, 2015
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the care of patients with orthopedic disorders, which are issues related to bones and muscles. The researchers at St Luc Hospital in Brussels want to see how different orthopedic treatments affect not just the physical structure (like bones and muscles) but also how these treatments influence patients' ability to move, perform daily activities, and participate in social and work life. They will use a special approach to evaluate these effects, which is not commonly used for musculoskeletal problems. By collecting detailed medical and computer data during surgeries, they aim to enhance the precision of surgical care and ultimately improve the quality of life for patients.
Anyone with orthopedic disorders, such as bone or muscle issues, can potentially participate in this trial. However, individuals with dementia or those who have trouble understanding instructions will not be eligible. Participants can expect to undergo assessments that will help researchers understand the impact of their treatments on various aspects of their lives, and they will contribute to efforts to improve future orthopedic care. This is an exciting opportunity to be part of a study that could lead to better management and outcomes for people facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients with orthopedic disorders : muscular skeletal impairment
- Exclusion Criteria:
- • Dementia patients with multiple disorders Patients who do not understand the instructions
About Cliniques Universitaires Saint Luc Université Catholique De Louvain
Cliniques Universitaires Saint-Luc, affiliated with the Université Catholique de Louvain, is a leading academic medical center in Belgium dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, it focuses on a wide range of therapeutic areas, prioritizing patient safety and ethical standards. The institution is committed to fostering collaboration between researchers and clinicians to enhance medical knowledge and improve treatment outcomes, contributing significantly to the global scientific community and the advancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Patients applied
Trial Officials
Olivier Cornu, MD,PhD
Principal Investigator
Cliniques universitaires St Luc Brussels
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials